Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: B.REVERE who wrote (1708)	4/27/1998 10:59:00 AM
From: Perry	Respond to of 9523

Here's the Reuters clip. Monday April 27, 10:31 am Eastern Time Viagra new Rx hit 113,134 in second week - auditor NEW YORK, April 27 (Reuters) - Pfizer Inc's (PFE - news) new impotence drug, Viagra, had 113,134 new prescriptions in the week ended April 17, the compound's second week on the market, auditing firm IMS America said Monday. The number compares with 36,263 new prescriptions written for the drug during the week of April 10, IMS told Reuters. IMS spokeswoman Nancy Duckwitz said Viagra's second week sales were impressive. By comparison, she said 2,071 new prescriptions were written for Warner-Lambert Co's (WLA - news) blockbuster anti-cholesterol drug Lipitor during its second week on the market in February 1997.